ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,473.23
0.77%
Dow Jones
38,778.10
0.49%
US Dollar vs MXN
18.4373
-0.53%
Brent Oil
83.725
-0.21%
Bitcoin
65,371.26
-1.68%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. AMEX
  6. Chad Therapeutics, (CTU)

  7. Chad Therapeutics, (CTU) Noticias

CTU

Chad Therapeutics (CTU)

Chad Therapeutics,
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:AMEX:CTU
FechaHoraFuenteTítuloSímboloCompañía
19/08/200805:00Edgar (US Regulatory)Chad Therapeutics Inc- (25)AMEX:CTUChad Therapeutics,
14/08/200815:25Edgar (US Regulatory)Chad Therapeutics Inc - Quarterly Report (10-Q)AMEX:CTUChad Therapeutics,
08/08/200813:54Edgar (US Regulatory)Chad Therapeutics Inc - Amended Current report filing (8-K/A)AMEX:CTUChad Therapeutics,
07/08/200815:15Business WireCHAD Therapeutics Plans to Begin Trading on the OTC Bulletin BoardAMEX:CTUChad Therapeutics,
04/08/200813:33Edgar (US Regulatory)Chad Therapeutics Inc - Current report filing (8-K)AMEX:CTUChad Therapeutics,
29/07/200810:50Business WireDormio Tech Division of CHAD Therapeutics Receives FDA Clearance to Market Its FloCHANNEL Sleep Diagnostic DeviceAMEX:CTUChad Therapeutics,
23/07/200816:32Business WireCHAD Therapeutics Receives Letter From The American Stock Exchange Citing Non-Compliance With Certain Listing RequirementsAMEX:CTUChad Therapeutics,
22/07/200816:45Business WireCHAD Therapeutics Reports Going Concern QualificationAMEX:CTUChad Therapeutics,
10/07/200812:41Edgar (US Regulatory)Chad Therapeutics Inc - Statement of Changes in Beneficial Ownership (4)AMEX:CTUChad Therapeutics,
27/06/200811:38Edgar (US Regulatory)Chad Therapeutics Inc - Annual Report (10-K)AMEX:CTUChad Therapeutics,
06/05/200816:54Edgar (US Regulatory)Chad Therapeutics Inc - Annual Statement of Changes in Beneficial Ownership (5)AMEX:CTUChad Therapeutics,
07/03/200806:30Business WireCHAD Therapeutics Closes Sale of Transfilling Assets for $1.825 Million in CashAMEX:CTUChad Therapeutics,
19/02/200806:30Business WireCHAD Therapeutics Closes Sale of Its Oxygen Business to INOVOAMEX:CTUChad Therapeutics,
14/02/200812:52Business WireCHAD Therapeutics Reports Third Quarter ResultsAMEX:CTUChad Therapeutics,
13/02/200809:37Edgar (US Regulatory)Chad Therapeutics Inc - Amended Statement of Ownership (SC 13G/A)AMEX:CTUChad Therapeutics,
31/01/200812:46Business WireCHAD Therapeutics Shareholders Approve Sale of Company's Oxygen Business to INOVOAMEX:CTUChad Therapeutics,
23/01/200805:00Edgar (US Regulatory)Chad Therapeutics Inc - Notice of Effectiveness (EFFECT)AMEX:CTUChad Therapeutics,
18/01/200813:25Edgar (US Regulatory)Chad Therapeutics Inc - Additional Proxy Soliciting Materials (definitive) (DEFA14A)AMEX:CTUChad Therapeutics,
10/01/200805:02Edgar (US Regulatory)Chad Therapeutics Inc - Securities Registration Statement (simplified form) (S-3)AMEX:CTUChad Therapeutics,
02/01/200806:30Business WireCHAD Therapeutics Announces Mailing of Definitive Proxy Regarding Proposed Sale of Its Oxygen BusinessAMEX:CTUChad Therapeutics,
28/12/200715:41Edgar (US Regulatory)Chad Therapeutics Inc - Proxy Statement (definitive) (DEF 14A)AMEX:CTUChad Therapeutics,
05/12/200705:02Edgar (US Regulatory)Chad Therapeutics Inc - Proxy Statement - Notice of Shareholders Meeting (preliminary) (PRE 14A)AMEX:CTUChad Therapeutics,
15/11/200705:02Edgar (US Regulatory)Chad Therapeutics Inc - Notification that Quarterly Report will be submitted late (NT 10-Q)AMEX:CTUChad Therapeutics,
19/09/200705:17Edgar (US Regulatory)Chad Therapeutics Inc (Other)AMEX:CTUChad Therapeutics,
14/08/200706:30Business WireCHAD Therapeutics Reports Fiscal 2008 First Quarter ResultsAMEX:CTUChad Therapeutics,
01/08/200706:30Business WireCHAD Therapeutics Completes $3.5 Million Financing PackageAMEX:CTUChad Therapeutics,
29/06/200712:00Business WireCHAD Therapeutics Reports Fourth Quarter and Fiscal 2007 ResultsAMEX:CTUChad Therapeutics,
25/04/200706:30Business WireCHAD Therapeutics Launches Advanced New Oxygen Conserver and Next-Generation Oxygen Transfilling System at Medtrade Show in LasAMEX:CTUChad Therapeutics,
14/11/200612:15Business WireCHAD Therapeutics Reports Fiscal 2007 Second Quarter and First Half Financial ResultsAMEX:CTUChad Therapeutics,
11/08/200606:30Business WireCHAD Therapeutics Reports Fiscal 2007 First Quarter Financial Results and Provides Update on Evaluation of Strategic OpportunitAMEX:CTUChad Therapeutics,
 Showing the most relevant articles for your search:AMEX:CTU

Su Consulta Reciente

EU
SNCBE
SNCF29127JAN51
BIT
EHYA
iShares EUR High Yield C...
NASDAQ
ARDIVX
Argus Dividend Growers M...
USOTC
ESXMF
Optegra Ventures (PK)
LSE
ZTF
Zotefoams
AMEX
SPVU
Invesco S&P 500 Enhanced...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados